Kawasaki syndrome is a diagnosis of exclusion. Treatment for this diagnosis may include IVIG and high dose aspirin therapy to prevent which condition?

Choice A rationale Chronic anemia is not a primary complication of Kawasaki syndrome. The disease process is a vasculitis that primarily affects medium-sized arteries, leading to inflammation and damage. The acute inflammatory state can cause temporary anemia, but it is not a chronic sequela prevented by IVIG and aspirin. Choice B rationale Cardiac arrhythmias are not the primary long-term complication targeted by IVIG and aspirin therapy. The main concern is the weakening of the coronary artery walls due to inflammation, which can lead to the formation of aneurysms. Arrhythmias can occur but are not the main focus of this specific treatment. Choice C rationale Acute respiratory distress is not a typical complication of Kawasaki syndrome. The syndrome is a systemic vasculitis, not a primary pulmonary disease. Respiratory symptoms like cough or runny nose are part of the initial presentation but are not the serious, life-threatening complication that IVIG and aspirin are given to prevent. Choice D rationale Coronary artery aneurysms are the most serious long-term complication of Kawasaki syndrome. The intense inflammation of the blood vessel walls, known as vasculitis, can lead to weakening and bulging of the coronary arteries. High-dose aspirin and IVIG reduce this systemic inflammation, thereby preventing the formation of these aneurysms.